Shionogi INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersFlorham Park, NJ
US patents1,012
SAM.gov UEIV8H8DT6RCHW6
CAGE code37UN1
Incorporated inDE
- treatments
- diseases
- antibiotics
- medications
- COVID-19
- Fragile X Syndrome
- patients worldwide
- global health challenges
- antimicrobial resistance
Named on the company’s own website, read JUL 29, 2026
Open positions
Openings read from Shionogi INC’s own job board on iCIMS, last checked OCT 30, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Senior Director/Executive Director, Trade RelationsShionogi INC · Florham Park, NJ · posted OCT 27, 2026
- Key Account Manager (KAM) - Hospitals; Anti-infectives - Phoenix, AZPhoenix, AZ · posted OCT 27, 2026
- Key Account Manager (KAM) - Hospitals; Anti-infectives - Atlanta, GAAtlanta, GA · posted OCT 27, 2026
- Senior Manager Scientific Affairs ALSShionogi INC · Florham Park, NJ · posted OCT 22, 2026
- Associate Sales Representative/Sales Representative - Primary Care - San Diego, CASan Diego, CA · posted OCT 21, 2026
- Neurology Account Specialist - Columbus, OHColumbus, OH · posted OCT 21, 2026
- Senior Manager, Regulatory Program Support (RPS)Shionogi INC · Florham Park, NJ · posted OCT 16, 2026
- Director, Trade Accounts (Remote)Shionogi INC · Florham Park, NJ · posted OCT 16, 2026
- Executive Director, Head of ProcurementShionogi INC · Florham Park, NJ · posted OCT 14, 2026
- Neurology Account Specialist - Los Angeles, CALos Angeles, CA · posted OCT 14, 2026
27 more on the company’s board
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
1,012 US patents granted 1976–2025, 48 of them in the five years to SEP 2025.
Organic fine chemistry 469Pharmaceuticals 419Biotechnology 54Measurement 36Basic materials chemistry 6
- Solid dosage form having excellent stabilityUS 12,427,156 · granted SEP 30, 2025
- Program generation assisting system for assisting generation of program for analyzing clinical trialUS 12,400,468 · granted AUG 26, 2025
- Production method for bifurcated lipid-linked oligonucleotide, and intermediateUS 12,351,804 · granted JUL 8, 2025
- Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivativesUS 12,350,377 · granted JUL 8, 2025
- Crystal of 1,3,5-triazine derivative or solvate thereof and method for producing sameUS 12,312,327 · granted MAY 27, 2025
Newest 5 shown · Granted to Shionogi & Co., LTD. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Shionogi INC | Florham Park | NJ | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


